TWD 20.9
(-0.71%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.02 TWD | -100.93% |
2022 | 1.34 TWD | 346.67% |
2021 | 0.30 TWD | -78.42% |
2020 | 1.39 TWD | -6.71% |
2019 | 1.49 TWD | -26.96% |
2018 | 2.04 TWD | 8.51% |
2017 | 1.88 TWD | 45.74% |
2016 | 1.29 TWD | -23.21% |
2015 | 1.68 TWD | 51.35% |
2014 | 1.11 TWD | -60.64% |
2013 | 2.82 TWD | 31.78% |
2012 | 2.14 TWD | 5.94% |
2011 | 2.02 TWD | 98.04% |
2010 | 1.02 TWD | -49.0% |
2009 | 2.00 TWD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | 0.25 TWD | 219.05% |
2024 Q2 | 0.29 TWD | 16.0% |
2023 Q4 | -0.21 TWD | -3381.25% |
2023 FY | - TWD | -100.93% |
2023 Q1 | 0.16 TWD | 365.78% |
2023 Q3 | 0.01 TWD | -94.67% |
2023 Q2 | 0.12 TWD | -25.0% |
2022 Q3 | 0.44 TWD | -15.38% |
2022 Q1 | 0.43 TWD | 2529.38% |
2022 FY | - TWD | 346.67% |
2022 Q4 | -0.06 TWD | -113.68% |
2022 Q2 | 0.52 TWD | 20.93% |
2021 Q1 | 0.32 TWD | -21.95% |
2021 FY | - TWD | -78.42% |
2021 Q4 | -0.02 TWD | -111.06% |
2021 Q3 | 0.16 TWD | 8988.89% |
2021 Q2 | -0.00 TWD | -100.56% |
2020 Q4 | 0.41 TWD | 36.67% |
2020 Q2 | 0.27 TWD | -55.74% |
2020 FY | - TWD | -6.71% |
2020 Q1 | 0.61 TWD | 38.64% |
2020 Q3 | 0.30 TWD | 11.11% |
2019 Q1 | 0.38 TWD | -28.3% |
2019 Q3 | 0.52 TWD | 52.94% |
2019 Q2 | 0.34 TWD | -10.53% |
2019 Q4 | 0.44 TWD | -15.38% |
2019 FY | - TWD | -26.96% |
2018 Q2 | 0.39 TWD | -32.76% |
2018 Q3 | 0.63 TWD | 61.54% |
2018 Q4 | 0.53 TWD | -15.87% |
2018 FY | - TWD | 8.51% |
2018 Q1 | 0.58 TWD | 38.1% |
2017 Q3 | 0.60 TWD | 25.0% |
2017 Q4 | 0.42 TWD | -30.0% |
2017 FY | - TWD | 45.74% |
2017 Q1 | 0.40 TWD | 48.15% |
2017 Q2 | 0.48 TWD | 20.0% |
2016 FY | - TWD | -23.21% |
2016 Q3 | 0.06 TWD | -86.45% |
2016 Q4 | 0.27 TWD | 374.52% |
2016 Q2 | 0.42 TWD | -27.59% |
2016 Q1 | 0.58 TWD | 45.0% |
2015 FY | - TWD | 51.35% |
2015 Q4 | 0.40 TWD | 0.0% |
2015 Q3 | 0.40 TWD | -2.44% |
2015 Q2 | 0.41 TWD | 13.89% |
2015 Q1 | 0.36 TWD | 71.43% |
2014 Q1 | 0.30 TWD | -40.0% |
2014 Q2 | 0.32 TWD | 6.67% |
2014 Q4 | 0.21 TWD | 0.0% |
2014 Q3 | 0.21 TWD | -34.38% |
2014 FY | - TWD | -60.64% |
2013 Q2 | 0.66 TWD | 0.0% |
2013 Q1 | 0.66 TWD | 57.14% |
2013 Q3 | 0.50 TWD | -24.24% |
2013 Q4 | 0.50 TWD | 0.0% |
2013 FY | - TWD | 31.78% |
2012 FY | - TWD | 5.94% |
2012 Q3 | 0.42 TWD | 0.0% |
2012 Q4 | 0.42 TWD | 0.0% |
2012 Q2 | - TWD | 0.0% |
2011 FY | - TWD | 98.04% |
2011 Q2 | - TWD | 0.0% |
2011 Q4 | - TWD | 0.0% |
2010 FY | - TWD | -49.0% |
2010 Q4 | - TWD | 0.0% |
2009 FY | - TWD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Excelsior Medical Co., Ltd. | 4.80 TWD | 99.521% |
Apex Medical Corp. | 1.51 TWD | 98.477% |
Applied BioCode Corporation | -2.01 TWD | 101.144% |